Mesenchymal stem cells promote liver regeneration and prolong survival in small-for-size liver grafts: Involvement of C-Jun N-terminal kinase, cyclin D1, and NF-κB

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Wang, Weijie ^a,b   Du, Zhiyong ^c   Yan, Jiqi ^a   Ma, Di ^a   Shi, Minmin ^a   Zhang, Mingjun ^a   Peng, Chenghong ^a   Li, Hongwei ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^c CENTRAL HOSPITAL OF WUHAN   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CYCLIN D1; CYCLINE; EPIDERMAL GROWTH FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; CCND1 PROTEIN, RAT;

ADIPOCYTE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CONTROLLED STUDY; GEL MOBILITY SHIFT ASSAY; GRAFT SURVIVAL; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; LIVER GRAFT; LIVER REGENERATION; LIVER TRANSPLANTATION; MALE; MESENCHYMAL STEM CELL; MORPHOLOGY; MORPHOMETRICS; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOBLAST; PROTEIN ANALYSIS; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMALL FOR SIZE LIVER TRANSPLANTATION; SURVIVAL RATE; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING; ANIMAL; BIOLOGICAL THERAPY; BIOSYNTHESIS; GENETICS; HUMAN; INFLAMMATION; LIVER CELL; MESENCHYMAL STROMA CELL; PATHOLOGY; REPERFUSION INJURY;

RATTUS;

ANIMALS; CELL DIFFERENTIATION; CELL- AND TISSUE-BASED THERAPY; CYCLIN D1; HEPATOCYTES; HUMANS; INFLAMMATION; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIVER REGENERATION; LIVER TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; NF-KAPPA B; RATS; REPERFUSION INJURY;

EID: 84917736132     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0112532     Document Type: Article

References (45)

1. Jeon H, Lee SG (2010) Living donor liver transplantation. Curr Opin Organ Tran 15: 283-287.
2. Nesher E, Island E, Tryphonopoulos P, Moon J, Nishida S, et al. (2011) Split liver transplantation. Transplant P 43: 1736-1741.
3. Fouraschen SM, Pan Q, de Ruiter PE, Farid WR, Kazemier G, et al. (2012) Secreted factors of human liver-derived mesenchymal stem cells promote liver regeneration early after partial hepatectomy. Stem Cells Dev 21: 2410-2419.
4. Fu WY, Yan JQ, Shi MM, Ma D, Peng CH, et al. (2013) Suppression of liver regeneration affects hepatic graft survival in small-for-size liver transplantation in rats. Hepatol Res 43: 300-310.
5. Zhong Z, Schwabe RF, Kai Y, He L, Yang L, et al. (2006) Liver regeneration is suppressed in small-forsize liver grafts after transplantation: involvement of c-Jun N-terminal kinase, cyclin D1, and defective energy supply. Transplantation 82: 241-250.
6. Jiang SM, Zhou GW, Zhang R, Peng CH, Yan JQ, et al. (2009) Role of splanchnic hemodynamics in liver regeneration after living donor liver transplantation. Liver Transplant 15: 1043-1049.
7. Meier RP, Müller YD, Morel P, Gonelle-Gispert C, Bühler LH (2013) Transplantation of mesenchymal stem cells for the treatment of liver diseases, is there enough evidence? Stem Cell Res 11: 1348-1364.
8. Esrefoglu M (2013) Role of stem cells in repair of liver injury: experimental and clinical benefit of transferred stem cells on liver failure. World J Gastroentero 19: 6757-6773.
9. Pan Q, Fouraschen SM, Kaya FS, Verstegen MM, Pescatori M, et al. (2011) Mobilization of hepatic mesenchymal stem cells from human liver grafts. Liver Transplant 17: 596-609.
10. Zhao W, Li JJ, Cao DY, Li X, Zhang LY, et al. (2012) Intravenous injection of mesenchymal stem cells is effective in treating liver fibrosis. World J Gastroentero 18: 1048-1058.
11. Xia X, Chen W, Ma T, Xu G, Liu H, et al. (2012) Mesenchymal stem cells administered after liver transplantation prevent acute graft-versus-host disease in rats. Liver Transplant 18: 696-706.
12. Salomone F, Barbagallo I, Puzzo L, Piazza C, Li Volti G (2013) Efficacy of adipose tissuemesenchymal stem cell transplantation in rats with acetaminophen liver injury. Stem Cell Res 11: 1037- 1044.
13. Bishi DK, Mathapati S, Cherian KM, Guhathakurta S, Verma RS (2014) In vitro hepatic transdifferentiation of human mesenchymal stem cells using sera from congestive/ischemic liver during cardiac failure. PLoS One 9: e92397.
14. Seki T, Yokoyama Y, Nagasaki H, Kokuryo T, Nagino M (2012) Adipose tissue-derived mesenchymal stem cell transplantation promotes hepatic regeneration after hepatic ischemia-reperfusion and subsequent hepatectomy in rats. Journal of Surgical Research 178: 63-70.
15. Malato Y, Ehedego H, AI-Masaoudi M, Cubero FJ, Bornemann J, et al. (2012) NF-kappaB essential modifier is required for hepatocyte proliferation and the oval cell reaction after partial hepatectomy in mice. Gastroenterology 143: 1597-1608.
16. van Poll D, Parekkadan B, Cho CH, Berthiaume F, Nahmias Y, et al. (2008) Mesenchymal stem cell- derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo. Hepatology 47: 1634-1643.
17. Kubo N, Narumi S, Kijima H, Mizukami H, Yagihashi S, et al. (2012) Efficacy of adipose tissue-derived mesenchymal stem cells for fulminant hepatitis in mice induced by concanavalin A. J Gastroen Hepatol 27: 165-172.
18. Shao CH, Chen SL, Dong TF, Chai H, Yu Y, et al. (2014) Transplantation of bone marrow-derived mesenchymal stem cells after regional hepatic irradiation ameliorates thioacetamide-induced liver fibrosis in rats. J Surg Res 186: 408-416.
19. Zhang H, Chen Z, Bie P (2012) Bone marrow-derived mesenchymal stem cells as immunosuppressants in liver transplantation: A review of current data. Transfus Med Rev 26: 129-141.
20. Rabani V, Shahsavani M, Gharavi M, Piryaei A, Azhdari Z, et al. (2010) Mesenchymal stem cell infusion therapy in a carbon tetrachloride-induced liver fibrosis model affects matrix metalloproteinase expression. Cell Biol Int 34: 601-605.
21. Niu J, Yue W, Song Y, Zhang Y, Qi X, et al. (2014) Prevention of acute liver allograft rejection by interleukin-10-engineered mesenchymal stem cells. Clin Exp Immunol 176: 473-484.
22. Yu Y, Lu L, Qian X, Chen N, Yao A, et al. (2010) Antifibrotic effect of hepatocyte growth factorexpressing mesenchymal stem cells in small-for-size liver transplant rats. Stem Cells Dev 19: 903-914.
23. Pan GZ, Yang Y, Zhang J, Liu W, Wang GY, et al. (2012) Bone marrow mesenchymal stem cells ameliorate hepatic ischemia/reperfusion injuries via inactivation of the MEK/ERK signaling pathway in rats. J Surg Res 178: 935-948.
24. Kuo TK, Hung SP, Chuang CH, Chen CT, Shih YRV, et al. (2008) Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells. Gastroenterology 134: 2111-2121.
25. Du Z, Wei C, Cheng K, Han B, Yan J, et al. (2013) Mesenchymal stem cell-conditioned medium reduces liver injury and enhances regeneration in reduced-size rat liver transplantation. Journal of Surgical Research 183: 907-915.
26. Lee KD, Kuo TKC, Whang-Peng J, Chung YF, Lin CT, et al. (2004) In vitro hepatic differentiation of human mesenchymal stem cells. Hepatology 40: 1275-1284.
27. Aurich I, Mueller LP, Aurich H, Luetzkendorf J, Tisljar K, et al. (2007) Functional integration of hepatocytes derived from human mesenchymal stem cells into mouse livers. Gut 56: 405-415.
28. Kamada N, Calne R (1983) A surgical experience with five hundred thirty liver transplants in the rat. Surgery 93: 64-69.
29. Wang W, Yan J, Wang H, Shi M, Zhang M, et al. (2014) Rapamycin ameliorates inflammation and fibrosis in the early phase of cirrhotic portal hypertension in rats through inhibition of mTORC1 but not mTORC2. PloS One 9: e83908.
30. Holden NS, Tacon CE (2011) Principles and problems of the electrophoretic mobility shift assay. J Pharmacol Toxicol 63: 7-14.
31. Jin X, Zhang Z, Beer-Stolz D, Zimmers TA, Koniaris LG (2007) Interleukin-6 inhibits oxidative injury and necrosis after extreme liver resection. Hepatology 46: 802-812.
32. Njoku DB, Li Z, Mellerson JL, Sharma R, Talor MV, et al. (2009) IP-10 protects while MIP-2 promotes experimental anesthetic hapten-induced hepatitis. J Autoimmun 32: 52-59.
33. Bone-Larson CL, Hogaboam CM, Evanhoff H, Strieter RM, Kunkel SL (2001) IFN-gamma-inducible protein-10 (CXCL10) is hepatoprotective during acute liver injury through the induction of CXCR2 on hepatocytes. J Immunol 167: 7077-7083.
34. Schwabe RF, Bradham CA, Uehara T, Hatano E, Bennett BL, et al. (2003) c-Jun-N-terminal kinase drives cyclin D1 expression and proliferation during liver regeneration. Hepatology 37: 824-832.
35. Behrens A, Sibilia M, David JP, Möhle-Steinlein U, Tronche F, et al. (2002) Impaired postnatal hepatocyte proliferation and liver regeneration in mice lacking c-jun in the liver. Embo J 21: 1782-1790.
36. Kanazawa H, Fujimoto Y, Teratani T, Iwasaki J, Kasahara N, et al. (2011) Bone marrow-derived mesenchymal stem cells ameliorate hepatic ischemia reperfusion injury in a rat model. PLoS One 6: e19195.
37. Yu Y, Yao AH, Chen N, Pu LY, Fan Y, et al. (2007) Mesenchymal stem cells over-expressing hepatocyte growth factor improve small-for-size liver grafts regeneration. Mol Ther 15: 1382-1389.
38. Stock P, Brückner S, Ebensing S, Hempel M, Dollinger MM, et al. (2010) The generation of hepatocytes from mesenchymal stem cells and engraftment into murine liver. Nat Protoc 5: 617-627.
39. Puglisi MA, Tesori V, Lattanzi W, Piscaglia AC, Gasbarrini GB, et al. (2011) Therapeutic implications of mesenchymal stem cells in liver injury. J Biomed Biotechnol 2011: 1-8.
40. Luk JM, Wang PP, Lee CK, Wang J, Fan S (2005) Hepatic potential of bone marrow stromal cells: development of in vitro co-culture and intra-portal transplantation models. J Immunol Methods 305: 39- 47.
41. Ma T, Liu H, Chen W, Xia X, Bai X, et al. (2012) Implanted adipose-derived stem cells attenuate smallfor- size liver graft injury by secretion of VEGF in rats. Am J Transplant 12: 620-629.
42. Yang ZF, Ho DWY, Ngai P, Lau CK, Zhao Y, et al. (2007) Antiinflammatory properties of IL-10 rescue small-for-size liver grafts. Liver Transplant 13: 558-565.
43. Schwabe RF, Brenner DA (2006) TNF-a-induced liver injury: role of IKK, JNK, and ROS pathways. Am J Physiol-Gastr L 290: G583-G589.
44. Tiberio L, Tiberio GA, Bardella L, Cervi E, Cerea K, et al. (2006) Mechanisms of interleukin-6 protection against ischemia-reperfusion injury in rat liver. Cytokine 34: 131-142.
45. Mangnall D, Bird NC, Majeed AW (2003) The molecular physiology of liver regeneration following partial hepatectomy. Liver int 23: 124-138.